Lazar Mandinov

Corporate Officer/Principal presso The European Society of Cardiology

Health Technology

Consumer Services

Posizioni attive di Lazar Mandinov

Società	Posizione	Inizio	Fine
The European Society of Cardiology	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
BOSTON SCIENTIFIC CORPORATION	Direttore Tecnico/Scientifico/R&S	-	-
Maine Medical Center Research	Corporate Officer/Principal	-	-
Mitralign, Inc. Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.	Direttore Tecnico/Scientifico/R&S	-	-

Medical University Sofia

Doctorate Degree

Distribuzione geografica

Posizioni

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Doctorate Degree	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
BOSTON SCIENTIFIC CORPORATION	Health Technology

Aziende private	3
Mitralign, Inc. Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.	Health Technology
The European Society of Cardiology
Maine Medical Center Research